India launches a single-window portal for medical device management
The Indian government has introduced the National Single Window System (NSWS) to streamline medical device import, clinical investigations, and testing processes. Initiated by the Centre, the NSWS serves as a comprehensive single-window platform, simplifying approval processes and enhancing the ease of doing business, as stated by Mr. Rajeev Raghuvanshi, the drugs controller general of India. Developed by Tata Consultancy Services (TCS), the NSWS portal supersedes existing platforms like SUGAM and cdscomdonline. It facilitates applications for certificates of registration and licenses related to medical device manufacturing or importation, including those for clinical investigations, tests, evaluations, demonstrations, and training. According to an official notice, the transition to NSWS involves disabling existing portals by January 15, 2024.
Finance Minister Mrs. Nirmala Sitharaman's vision for an investment clearance cell (ICC) has materialized in the form of NSWS. The system empowers investors to identify, apply, track, and obtain necessary approvals efficiently, eliminating the need to navigate multiple IT platforms and authorities, as detailed in a notice from the Central Drugs Standard Control Organisation (CDSCO).
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.